When we look at Bitcoin’s price, the concern extends to the altcoins as well; however, it should also extend to the companies associated with BTC-related activities.
In line with the same, BeInCrypto has analysed three Bitcoin mining companies’ stock performance and what lies ahead for them.
BitMine Immersion Technologies (BMNR)
BMNR has dropped 24% this week and trades at $30.95. Despite the decline, Bitmine has continued accumulating ETH, adding 54,156 ETH worth more than $170 million over the past seven days. This signals a strong long-term conviction from the company.
The RSI is nearing the oversold zone, which often precedes a reversal. If conditions stabilize, BMNR could rebound from the $30.88 support and climb toward $34.94 or even $37.27, offering relief after a week of heavy losses.
Want more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.
BMNR Price Analysis. Source: TradingView
If Bitcoin weakens further, BMNR may follow the broader downturn. A deeper decline could send the stock below $27.80, with potential downside extending to $24.64. This would invalidate the bullish outlook and signal intensified bearish momentum.
Bitdeer Technologies Group (BTDR)
Bitdeer has recorded some of the steepest losses among Bitcoin mining stocks, falling 53% over seven sessions. The share price now sits at $10.63, reflecting intense selling pressure as broader market weakness continues to weigh on mining companies.
BTDR’s RSI is deep in the oversold zone, signaling conditions that often precede a reversal. If buyers step in, the stock could rebound from $9.56 and move toward $11.92, with potential upside extending to $15.24 if momentum strengthens.
BTDR Price Analysis. Source: TradingView
If market conditions fail to improve, BTDR could continue its decline. A breakdown below $9.56 may drive the price toward $7.96. This would invalidate the bullish outlook and signal an extended downside for the mining firm.
HIVE Digital Technologies Ltd. (HIVE)
Bitcoin mining company HIVE has dropped 29% over the past week but now trades at $3.56 after gaining 7.5% today. The surge follows the company’s announcement of 285% revenue growth in Q2, which has boosted investor confidence despite recent volatility.
This strong performance could fuel a broader recovery and lift HIVE toward $4.04. Restoring recent losses would require a move to $5.09. Reaching this target may take time, but it remains possible if momentum and sentiment continue improving.
HIVE Price Analysis. Source: TradingView
If the stock fails to capitalize on the company’s earnings strength, HIVE may resume its decline. A drop toward the $3.00 support level or lower would invalidate the bullish thesis and signal renewed weakness.
